Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Girerd

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
The European Respiratory Journal|March 25, 2016
Pulmonary veno-occlusive diseaseDavid Montani, Edmund M Lau, Peter Dorfmüller, et al.
International Journal of Molecular Sciences|October 10, 2020
Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular CellsHélène Le Ribeuz, Florent Dumont, Guillaume Ruellou, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodentsLy Tu, Frances S De Man, Barbara Girerd, et al.
American Journal of Respiratory and Critical Care Medicine|June 4, 2015
Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary HypertensionVéronique Freund-Michel, Marcelina Cardoso Dos Santos, Christophe Guignabert, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2010
Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutationBarbara Girerd, David Montani, Florence Coulet, et al.
Nature Genetics|December 3, 2013
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertensionMélanie Eyries, David Montani, Barbara Girerd, et al.
The European Respiratory Journal|December 25, 2015
Genetic counselling in a national referral centre for pulmonary hypertensionBarbara Girerd, David Montani, Xavier Jaïs, et al.
The Canadian Journal of Cardiology|August 5, 2015
Usefulness of Cardiovascular Magnetic Resonance Indices to Rule In or Rule Out Precapillary Pulmonary HypertensionNicolas Creuzé, Susana Hoette, David Montani, et al.
The European Respiratory Journal|November 5, 2016
BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertensionMaria-Rosa Ghigna, Christophe Guignabert, David Montani, et al.
American Journal of Respiratory Cell and Molecular Biology|February 17, 2022
SUR1 As a New Therapeutic Target for Pulmonary Arterial HypertensionHélène Le Ribeuz, Bastien Masson, Véronique Capuano, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
The European Respiratory Journal|March 25, 2016
Pulmonary veno-occlusive diseaseDavid Montani, Edmund M Lau, Peter Dorfmüller, et al.
International Journal of Molecular Sciences|October 10, 2020
Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular CellsHélène Le Ribeuz, Florent Dumont, Guillaume Ruellou, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodentsLy Tu, Frances S De Man, Barbara Girerd, et al.
American Journal of Respiratory and Critical Care Medicine|June 4, 2015
Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary HypertensionVéronique Freund-Michel, Marcelina Cardoso Dos Santos, Christophe Guignabert, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2010
Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutationBarbara Girerd, David Montani, Florence Coulet, et al.
Nature Genetics|December 3, 2013
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertensionMélanie Eyries, David Montani, Barbara Girerd, et al.
The European Respiratory Journal|December 25, 2015
Genetic counselling in a national referral centre for pulmonary hypertensionBarbara Girerd, David Montani, Xavier Jaïs, et al.
The Canadian Journal of Cardiology|August 5, 2015
Usefulness of Cardiovascular Magnetic Resonance Indices to Rule In or Rule Out Precapillary Pulmonary HypertensionNicolas Creuzé, Susana Hoette, David Montani, et al.
The European Respiratory Journal|November 5, 2016
BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertensionMaria-Rosa Ghigna, Christophe Guignabert, David Montani, et al.
American Journal of Respiratory Cell and Molecular Biology|February 17, 2022
SUR1 As a New Therapeutic Target for Pulmonary Arterial HypertensionHélène Le Ribeuz, Bastien Masson, Véronique Capuano, et al.
Pageof 10